MedPath

Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease

Phase 3
Completed
Conditions
Anxiety
Depression
Parkinson's Disease
Insomnia
Interventions
Behavioral: ICONTROL
Behavioral: ICBT
Registration Number
NCT01545414
Lead Sponsor
Karolinska Institutet
Brief Summary

The purpose of this project is to develop and evaluate Internet-based Cognitive Behavioral Therapy (ICBT) for Parkinson's Disease (PD) patients with concurrent depression or anxiety symptoms. All treatment in this project is given as an adjunct to Standard Medical Treatment (SMT). ICBT will be compared to an Internet-based active control treatment (ICONTROL) and to SMT alone. It is hypothesized that both active treatments will be superior to SMT, and that ICBT will be superior to ICONTROL, in reducing symptoms of depression and anxiety.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Clinical diagnosis of Parkinson's Disease
  • At least mild to moderate depression or anxiety defined as HADS-A or HADS-D > 7
Exclusion Criteria
  • Has a high alcohol or drug use assessed by the AUDIT / DUDIT and assessment interview
  • Somatic or psychiatric problems that are directly contraindicated or seriously hamper the implementation of the treatment (eg, psychotic disorders or bipolar disorder)
  • Difficulties that hamper the use of a computer
  • The patient states difficulties in finding enough time for treatment
  • Too low cognitive functioning defined as MoCA < 24
  • Too severe depression, defined as MADRS-S over 30
  • Too high suicidal risk defined as more than 4 points on the MADRS-S question 9 or according to the structured assessment interview

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ICONTROLICONTROLInternet-based treatment with a focus on relaxation training
ICBTICBTInternet-based Cognitive Behavioral Therapy with a focus on behavioral activation
Primary Outcome Measures
NameTimeMethod
Change (from baseline) in HADS12 weeks (Post), 3 and 6 months (FU)

Hospital Anxiety and Depression Scale - self rating, to measure anxiety and depression

Secondary Outcome Measures
NameTimeMethod
Change (from baseline) in MADRS-S12 weeks (Post), 3 and 6 months (FU)

Montgomery and Asberg Depressions Rating Scale - Self report, to measure level of depression

Change (from baseline) in ISI12 weeks (Post), 3 and 6 months (FU)

Insomnia Severity Index - self-report, to measure insomnia symptoms

Change (from baseline) in PDQ-812 weeks (Post), 3 and 6 months (FU)

The Parkinson's Disease Questionnaire-8, to measure various health aspects specific for PD patients

Change (from baseline) in NMSQuest12 weeks (Post), 3 and 6 months (FU)

Non-Motor Symptoms Questionnaire, to measure the non-motor symptoms in PD

Change (from baseline) in EQ-5D12 weeks (Post), 3 and 6 months (FU)

EQ-5D, to measure general health and quality of life

Change (from baseline) in SDS12 weeks (Post), 3 and 6 months (FU)

Sheehan Disability Scale, to measure everyday level of functioning

Trial Locations

Locations (1)

Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath